Estimation of blood-based biomarkers of glial activation related to neuroinflammation.

Alzheimer’s disease (AD) Blood-based biomarkers Monocyte chemotactic protein 1 (MCP-1) Neuroinflammation Positron emission tomography (PET) Soluble triggering receptor expressed on myeloid cells 2 (sTREM2)

Journal

Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 19 07 2022
revised: 08 10 2022
accepted: 30 10 2022
entrez: 17 11 2022
pubmed: 18 11 2022
medline: 18 11 2022
Statut: epublish

Résumé

Neuroinflammation is a well-known feature of Alzheimer's disease (AD), and a blood-based test for estimating the levels of neuroinflammation would be expected. In this study, we examined and validated a model using blood-based biomarkers to predict the level of glial activation due to neuroinflammation, as estimated by We included 15 patients with AD and 10 cognitively normal (CN) subjects. Stepwise backward deletion multiple regression analysis was used to determine the predictors of the TSPO-binding potential (BP Sex, diagnosis, and serum concentrations of MCP1 and sTREM2 were determined as predictors of TSPO-BP We found that the model including serum MCP-1 and sTREM2 concentration and covariates of sex and diagnosis was the best for predicting brain TSPO-BP

Sections du résumé

Background UNASSIGNED
Neuroinflammation is a well-known feature of Alzheimer's disease (AD), and a blood-based test for estimating the levels of neuroinflammation would be expected. In this study, we examined and validated a model using blood-based biomarkers to predict the level of glial activation due to neuroinflammation, as estimated by
Methods UNASSIGNED
We included 15 patients with AD and 10 cognitively normal (CN) subjects. Stepwise backward deletion multiple regression analysis was used to determine the predictors of the TSPO-binding potential (BP
Results UNASSIGNED
Sex, diagnosis, and serum concentrations of MCP1 and sTREM2 were determined as predictors of TSPO-BP
Conclusions UNASSIGNED
We found that the model including serum MCP-1 and sTREM2 concentration and covariates of sex and diagnosis was the best for predicting brain TSPO-BP

Identifiants

pubmed: 36388135
doi: 10.1016/j.bbih.2022.100549
pii: S2666-3546(22)00139-9
pmc: PMC9650015
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100549

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare no potential conflicts of interest.

Références

Brain Pathol. 2009 Jul;19(3):392-8
pubmed: 18637012
Alzheimers Dement. 2022 Oct;18(10):1868-1879
pubmed: 34936194
Biol Psychiatry. 2015 Jan 1;77(1):43-51
pubmed: 24951455
Int J Neurosci. 2017 Feb;127(2):161-175
pubmed: 26887612
Mol Neurodegener. 2016 Jan 12;11:3
pubmed: 26754172
J Infect Dis. 1997 Feb;175(2):478-81
pubmed: 9203678
Nat Commun. 2019 Mar 25;10(1):1365
pubmed: 30911003
Psychiatry Res. 2012 Jul 30;203(1):67-74
pubmed: 22892349
J Lipid Res. 1990 Mar;31(3):545-8
pubmed: 2341813
Neurobiol Aging. 2013 Apr;34(4):1060-8
pubmed: 23040664
Neurobiol Aging. 2006 Dec;27(12):1763-8
pubmed: 16307829
Brain Plast. 2018 Dec 12;4(1):53-63
pubmed: 30564546
Alzheimers Res Ther. 2022 Jan 7;14(1):5
pubmed: 34996522
Neuropathology. 2006 Aug;26(4):307-12
pubmed: 16961066
Neurobiol Aging. 2007 Apr;28(4):533-6
pubmed: 16569464
J Neuroimmunol. 1999 Jan 1;93(1-2):182-93
pubmed: 10378882
Brain. 2019 Sep 1;142(9):2581-2589
pubmed: 31497858
J Biol Chem. 2013 Nov 15;288(46):33027-36
pubmed: 24078628
J Nucl Med. 2007 Apr;48(4):573-81
pubmed: 17401094
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
BMC Neurol. 2011 May 12;11:51
pubmed: 21569380
Neuron. 2018 Mar 7;97(5):1023-1031.e7
pubmed: 29518356
Trends Pharmacol Sci. 2006 Aug;27(8):402-9
pubmed: 16822554
EMBO Mol Med. 2018 Nov;10(11):
pubmed: 30341064
Mol Neurodegener. 2022 Sep 24;17(1):62
pubmed: 36153580
J Immunol. 1996 Aug 1;157(3):1213-8
pubmed: 8757628
Biol Psychiatry. 2010 Nov 15;68(10):903-12
pubmed: 21035623
Dialogues Clin Neurosci. 2016 Dec;18(4):437-446
pubmed: 28179815
Cell Biosci. 2020 Sep 15;10:109
pubmed: 32944223
J Alzheimers Dis. 2014;42(3):901-8
pubmed: 25024322
Nat Rev Immunol. 2018 Dec;18(12):759-772
pubmed: 30140051
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
J Neuroinflammation. 2012 Jul 02;9:151
pubmed: 22747753
Alzheimers Res Ther. 2019 Jan 12;11(1):5
pubmed: 30636644
J Neurol. 2011 Dec;258(12):2181-5
pubmed: 21562723
Glia. 2008 Oct;56(13):1438-47
pubmed: 18551625
Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412
pubmed: 25561720
J Exp Med. 2015 Mar 9;212(3):287-95
pubmed: 25732305
Arq Neuropsiquiatr. 2011 Jun;69(3):455-9
pubmed: 21755121
Biol Psychiatry. 2008 Nov 15;64(10):835-41
pubmed: 18514164
J Nucl Med. 2011 Jan;52(1):24-32
pubmed: 21149489
Arch Gen Psychiatry. 1998 Sep;55(9):809-15
pubmed: 9736007
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
PLoS One. 2012;7(9):e44260
pubmed: 23028511
Neuroimage. 2008 Mar 1;40(1):43-52
pubmed: 18093844
Am J Pathol. 2011 Sep;179(3):1373-84
pubmed: 21777559
Mol Neurodegener. 2014 Jun 03;9:20
pubmed: 24893973
Alzheimers Dement. 2022 Mar 2;:
pubmed: 35234337
Dement Geriatr Cogn Disord. 2009;28(6):507-12
pubmed: 19996595
Alzheimers Dement. 2019 Mar;15(3):453-464
pubmed: 30442540
Diagnostics (Basel). 2021 Aug 24;11(9):
pubmed: 34573867
Ann Neurol. 2019 Jan;85(1):47-58
pubmed: 30485483
J Alzheimers Dis. 2010;20 Suppl 2:S527-33
pubmed: 20442496
J Neuroinflammation. 2010 Jun 11;7:34
pubmed: 20540736
Front Neurosci. 2019 May 22;13:508
pubmed: 31191220
Exp Neurol. 2004 Dec;190(2):446-55
pubmed: 15530883
Mol Med. 1998 Jul;4(7):480-9
pubmed: 9713826
J Neurochem. 2005 May;93(4):1038-46
pubmed: 15857407
Dement Geriatr Cogn Dis Extra. 2015 Nov 24;5(3):424-34
pubmed: 26675645
Biochim Biophys Acta Mol Basis Dis. 2022 Jul 1;1868(7):166384
pubmed: 35292360
Nucl Med Biol. 2022 May-Jun;108-109:76-84
pubmed: 35349913
J Neurocytol. 2004 Sep;33(5):535-41
pubmed: 15906160
Brain Behav Immun. 2017 May;62:203-211
pubmed: 28161476
Glia. 2000 Feb 15;29(4):305-15
pubmed: 10652441
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Brain Pathol. 2018 Sep;28(5):595-602
pubmed: 28987033
Neurosci Lett. 1991 Aug 19;129(2):318-20
pubmed: 1745413
Cell. 2013 Apr 25;153(3):707-20
pubmed: 23622250
Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):54-61
pubmed: 23242124

Auteurs

Fumihiko Yasuno (F)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Atsushi Watanabe (A)

Equipment Management Division, Center for Core Facility Administration, National Center for Geriatrics and Gerontology, Obu, Japan.

Yasuyuki Kimura (Y)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Yumeka Yamauchi (Y)

Equipment Management Division, Center for Core Facility Administration, National Center for Geriatrics and Gerontology, Obu, Japan.

Aya Ogata (A)

Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science, Kani, Japan.

Hiroshi Ikenuma (H)

Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Junichiro Abe (J)

Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Hiroyuki Minami (H)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Takashi Nihashi (T)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Kastunori Yokoi (K)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Saori Hattori (S)

Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Nobuyoshi Shimoda (N)

Molecular Analysis Division, Center for Core Facility Administration, National Center for Geriatrics and Gerontology, Obu, Japan.

Kensaku Kasuga (K)

Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.

Takeshi Ikeuchi (T)

Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.

Akinori Takeda (A)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Takashi Sakurai (T)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Kengo Ito (K)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Takashi Kato (T)

National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.

Classifications MeSH